US Patent Issued to 1ST Biotherapeutics on Jan. 27 for "Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders" (South Korean Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,461, issued on Jan. 27, was assigned to 1ST Biotherapeutics Inc. (Gyeonggi-do, South Korea).

"Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders" was invented by Jinhwa Lee (Gyeonggi-do, South Korea), Suyeon Jo (Gyeonggi-do, South Korea), Keonseung Lim (Gyeonggi-do, South Korea), A Yeong Park (Gyeonggi-do, South Korea), Jae Eun Kim (Gyeonggi-do, South Korea), Misoon Kim (Gyeonggi-do, South Korea) and Seung Mook Lim (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salt, stereoisomers thereof, a pharmace...